New Survey: Parent’s Seeking Help for, and Care of, a Sick or Unwell Child During COVID-19 ‘Stay at Home’ Period
28 May 2020 / Posted in: Information, Support
The University of Plymouth has launched this survey as it's hoped the results will advance understanding of how these extraordinary times are affecting parents' thinking about, and perception of, access to services for children when they are sick or unwell.
AveXis UK Updates the Community on Progress Towards Access to Zolgensma
28 May 2020 / Posted in: Treatments & Research
We received this update today in response to our questions around progress towards access in the UK.
Invitation to Join Study: Experiences of Living With, or Caring for Someone who has, SMA
21 May 2020 / Posted in: Information, Support
A healthcare market research company working for a research client and pharmaceutical company wants to understand patient and caregiver journeys and any treatment routines. Participants will be paid £35 for each completed survey, with 10% donated to one of the company's registered charities. Registrations of interest close 29th May.
AveXis receives European Commission (EC) approval for the gene therapy Zolgensma®
19 May 2020 / Posted in: Treatments & Research
The EC has granted approval for Zolgensma® for the treatment of babies and young children who have 5q SMA with a bi-allelic mutation in the SMN1 gene and either a clinical diagnosis of SMA Type 1 or up to three copies of the SMN2 gene.
NICE & NHS England Answer Nusinersen FAQs on MAA and Access for Children
19 May 2020 / Posted in: Treatments & Research
We finally have answers to some of the questions the patient groups asked NHS England and NICE in August 2019. Other FAQs posed were about access for adults, data collection and the treatment itself. These should be coming soon.
Do you live with a neuromuscular condition and experience swallowing difficulties, or care for someone who does?
18 May 2020 / Posted in: Information, Support
If so, please consider sharing your experiences by completing an online survey led by a specialist team at The National Hospital for Neurology and University College London. Survey closes 26th July.
PhD Scholarship Funding Cancelled This Year
18 May 2020 / Posted in: Treatments & Research
Due to the financial effect COVID-19 is having on Muscular Dystrophy UK’s ability to generate income, they have with great regret had to cancel their 2020 Grant Round. This includes the PhD scholarship scheme we were undertaking jointly with them. Sadly due to the impact on our funding as well, it would be unrealistic for SMA UK to organise our own process.
International Research Survey: Coronavirus
14 May 2020 / Posted in: Information, Support
A collaboration of international researchers, including researchers from University College London, are interested in how the current coronavirus pandemic is affecting disabled people and their families.
Scholar Rock Reports Delays in Interim Trial Results Due to COVID-19
13 May 2020 / Posted in: Treatments & Research
Scholar Rock reported on the recent progress and upcoming milestones for the TOPAZ Phase 2 clinical trial of SRK-015 in patients who have SMA Type 2 or 3, in the light of the COVID-19 pandemic.
Research Survey to Understand the Impact of COVID-19 on People who have a Rare Disease, and their Caregivers
12 May 2020 / Posted in: Information, Support
Researchers at Queen’s University Belfast and University of Aberdeen are conducting this online international survey. It's available to complete until the end of May.
